Illumina's CEO Promises Growth By 2027, Because Patience Is A Strategy
Jacob Thaysen, Illumina's fearless captain navigating the turbulent biotech seas, insists they're still on course for a modest 'high single-digit revenue growth' by the distant shores of 2027. Despite unexpected headwindsâlikely a fancy euphemism for market chaos, supply chain mayhem, or maybe his coffee machine breakingâthe CEO remains optimistic. Illumina, known for turning DNA into some kind of money magic, apparently believes five more years of slow growth is an acceptable life strategy. It's 2024, investors might just want to pop some popcorn and enjoy the slowest rollercoaster ride in corporate history.
Share the Story
Illuminaâs CEO is basically telling investors, 'Hang tight, itâs a glacier-speed race to glory by 2027,' because nothing screams excitement like three years to reach what a startup might pull off in six months.
Who needs quarterly fireworks when you can watch Illuminaâs revenue growth crawl at a snailâs pace through 2027? CEO must think investors love suspenseful slow burns.
Illuminaâs strategy: convince Wall Street that waiting for 'high single-digit growth' five years from now is a thrilling binge-watch, not a patience test.
Source: Statnews | Published: 8/26/2025 | Author: Jonathan Wosen
More Articles in Business
Politico Announces Australia Launch for 2026, Because Why Not Start Late?
Trump Promises Retirement Plan That Matches Generosity of Federal Workersâ Excuses
Trump Calls Supreme Court 'Unfortunate,' Then Hits Economy with âBetterâ 10% Global Tariff
Workday CEO Wonders Who to Replace with AI Before Deciding to Lay Off 400 Humans
David Ellisonâs 10th WBD Offer: Slightly Better Than Doing Nothing
AI Slaps White-Collar Jobs, Blue-Collars Brace for Gig Economy Chain Reaction
Costco, Toyota & FedEx Sue Trump For Tariff Refunds Like Itâs Black Friday Cashback
Lamborghini Cancels Silent EV, Citing Absence of Vroom-Feelz
